- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings.
According to our latest study, the global Anti-Venom market size was valued at USD 987 million in 2022 and is forecast to a readjusted size of USD 1300.5 million by 2029 with a CAGR of 4.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.
This report is a detailed and comprehensive analysis for global Anti-Venom market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Anti-Venom market size and forecasts, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029
Global Anti-Venom market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029
Global Anti-Venom market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029
Global Anti-Venom market shares of main players, shipments in revenue ($ Million), sales quantity (K Vials), and ASP (USD/Vial), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-Venom
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-Venom market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Merck, BTG, Pfizer and Haffkine Bio-Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Anti-Venom market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Polyvalent Anti-Venom
Monovalent Anti-Venom
Market segment by Application
Non-profit Institutions
Hospitals and Clinic
Major players covered
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Venom product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-Venom, with price, sales, revenue and global market share of Anti-Venom from 2018 to 2023.
Chapter 3, the Anti-Venom competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Venom breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Anti-Venom market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-Venom.
Chapter 14 and 15, to describe Anti-Venom sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Anti-Venom
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-Venom Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Polyvalent Anti-Venom
1.3.3 Monovalent Anti-Venom
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-Venom Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Non-profit Institutions
1.4.3 Hospitals and Clinic
1.5 Global Anti-Venom Market Size & Forecast
1.5.1 Global Anti-Venom Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-Venom Sales Quantity (2018-2029)
1.5.3 Global Anti-Venom Average Price (2018-2029)
2 Manufacturers Profiles
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Anti-Venom Product and Services
2.1.4 CSL Anti-Venom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CSL Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Anti-Venom Product and Services
2.2.4 Merck Anti-Venom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 BTG
2.3.1 BTG Details
2.3.2 BTG Major Business
2.3.3 BTG Anti-Venom Product and Services
2.3.4 BTG Anti-Venom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BTG Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Anti-Venom Product and Services
2.4.4 Pfizer Anti-Venom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 Haffkine Bio-Pharmaceutical
2.5.1 Haffkine Bio-Pharmaceutical Details
2.5.2 Haffkine Bio-Pharmaceutical Major Business
2.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Product and Services
2.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
2.6 Rare Disease Therapeutics
2.6.1 Rare Disease Therapeutics Details
2.6.2 Rare Disease Therapeutics Major Business
2.6.3 Rare Disease Therapeutics Anti-Venom Product and Services
2.6.4 Rare Disease Therapeutics Anti-Venom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Rare Disease Therapeutics Recent Developments/Updates
2.7 Flynn Pharma
2.7.1 Flynn Pharma Details
2.7.2 Flynn Pharma Major Business
2.7.3 Flynn Pharma Anti-Venom Product and Services
2.7.4 Flynn Pharma Anti-Venom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Flynn Pharma Recent Developments/Updates
2.8 Vins Bioproducts
2.8.1 Vins Bioproducts Details
2.8.2 Vins Bioproducts Major Business
2.8.3 Vins Bioproducts Anti-Venom Product and Services
2.8.4 Vins Bioproducts Anti-Venom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Vins Bioproducts Recent Developments/Updates
2.9 Bharat Serums and Vaccines
2.9.1 Bharat Serums and Vaccines Details
2.9.2 Bharat Serums and Vaccines Major Business
2.9.3 Bharat Serums and Vaccines Anti-Venom Product and Services
2.9.4 Bharat Serums and Vaccines Anti-Venom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bharat Serums and Vaccines Recent Developments/Updates
2.10 Serum Biotech
2.10.1 Serum Biotech Details
2.10.2 Serum Biotech Major Business
2.10.3 Serum Biotech Anti-Venom Product and Services
2.10.4 Serum Biotech Anti-Venom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Serum Biotech Recent Developments/Updates
2.11 MicroPharm
2.11.1 MicroPharm Details
2.11.2 MicroPharm Major Business
2.11.3 MicroPharm Anti-Venom Product and Services
2.11.4 MicroPharm Anti-Venom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 MicroPharm Recent Developments/Updates
3 Competitive Environment: Anti-Venom by Manufacturer
3.1 Global Anti-Venom Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-Venom Revenue by Manufacturer (2018-2023)
3.3 Global Anti-Venom Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-Venom by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-Venom Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-Venom Manufacturer Market Share in 2022
3.5 Anti-Venom Market: Overall Company Footprint Analysis
3.5.1 Anti-Venom Market: Region Footprint
3.5.2 Anti-Venom Market: Company Product Type Footprint
3.5.3 Anti-Venom Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Anti-Venom Market Size by Region
4.1.1 Global Anti-Venom Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-Venom Consumption Value by Region (2018-2029)
4.1.3 Global Anti-Venom Average Price by Region (2018-2029)
4.2 North America Anti-Venom Consumption Value (2018-2029)
4.3 Europe Anti-Venom Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-Venom Consumption Value (2018-2029)
4.5 South America Anti-Venom Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-Venom Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Anti-Venom Sales Quantity by Type (2018-2029)
5.2 Global Anti-Venom Consumption Value by Type (2018-2029)
5.3 Global Anti-Venom Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Anti-Venom Sales Quantity by Application (2018-2029)
6.2 Global Anti-Venom Consumption Value by Application (2018-2029)
6.3 Global Anti-Venom Average Price by Application (2018-2029)
7 North America
7.1 North America Anti-Venom Sales Quantity by Type (2018-2029)
7.2 North America Anti-Venom Sales Quantity by Application (2018-2029)
7.3 North America Anti-Venom Market Size by Country
7.3.1 North America Anti-Venom Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-Venom Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Anti-Venom Sales Quantity by Type (2018-2029)
8.2 Europe Anti-Venom Sales Quantity by Application (2018-2029)
8.3 Europe Anti-Venom Market Size by Country
8.3.1 Europe Anti-Venom Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-Venom Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Anti-Venom Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-Venom Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-Venom Market Size by Region
9.3.1 Asia-Pacific Anti-Venom Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-Venom Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Anti-Venom Sales Quantity by Type (2018-2029)
10.2 South America Anti-Venom Sales Quantity by Application (2018-2029)
10.3 South America Anti-Venom Market Size by Country
10.3.1 South America Anti-Venom Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-Venom Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Anti-Venom Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-Venom Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-Venom Market Size by Country
11.3.1 Middle East & Africa Anti-Venom Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-Venom Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Anti-Venom Market Drivers
12.2 Anti-Venom Market Restraints
12.3 Anti-Venom Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Anti-Venom and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-Venom
13.3 Anti-Venom Production Process
13.4 Anti-Venom Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-Venom Typical Distributors
14.3 Anti-Venom Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Anti-Venom Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-Venom Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CSL Basic Information, Manufacturing Base and Competitors
Table 4. CSL Major Business
Table 5. CSL Anti-Venom Product and Services
Table 6. CSL Anti-Venom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CSL Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Anti-Venom Product and Services
Table 11. Merck Anti-Venom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Recent Developments/Updates
Table 13. BTG Basic Information, Manufacturing Base and Competitors
Table 14. BTG Major Business
Table 15. BTG Anti-Venom Product and Services
Table 16. BTG Anti-Venom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BTG Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Anti-Venom Product and Services
Table 21. Pfizer Anti-Venom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Haffkine Bio-Pharmaceutical Major Business
Table 25. Haffkine Bio-Pharmaceutical Anti-Venom Product and Services
Table 26. Haffkine Bio-Pharmaceutical Anti-Venom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 28. Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
Table 29. Rare Disease Therapeutics Major Business
Table 30. Rare Disease Therapeutics Anti-Venom Product and Services
Table 31. Rare Disease Therapeutics Anti-Venom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Rare Disease Therapeutics Recent Developments/Updates
Table 33. Flynn Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Flynn Pharma Major Business
Table 35. Flynn Pharma Anti-Venom Product and Services
Table 36. Flynn Pharma Anti-Venom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Flynn Pharma Recent Developments/Updates
Table 38. Vins Bioproducts Basic Information, Manufacturing Base and Competitors
Table 39. Vins Bioproducts Major Business
Table 40. Vins Bioproducts Anti-Venom Product and Services
Table 41. Vins Bioproducts Anti-Venom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Vins Bioproducts Recent Developments/Updates
Table 43. Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
Table 44. Bharat Serums and Vaccines Major Business
Table 45. Bharat Serums and Vaccines Anti-Venom Product and Services
Table 46. Bharat Serums and Vaccines Anti-Venom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Bharat Serums and Vaccines Recent Developments/Updates
Table 48. Serum Biotech Basic Information, Manufacturing Base and Competitors
Table 49. Serum Biotech Major Business
Table 50. Serum Biotech Anti-Venom Product and Services
Table 51. Serum Biotech Anti-Venom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Serum Biotech Recent Developments/Updates
Table 53. MicroPharm Basic Information, Manufacturing Base and Competitors
Table 54. MicroPharm Major Business
Table 55. MicroPharm Anti-Venom Product and Services
Table 56. MicroPharm Anti-Venom Sales Quantity (K Vials), Average Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. MicroPharm Recent Developments/Updates
Table 58. Global Anti-Venom Sales Quantity by Manufacturer (2018-2023) & (K Vials)
Table 59. Global Anti-Venom Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Anti-Venom Average Price by Manufacturer (2018-2023) & (USD/Vial)
Table 61. Market Position of Manufacturers in Anti-Venom, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Anti-Venom Production Site of Key Manufacturer
Table 63. Anti-Venom Market: Company Product Type Footprint
Table 64. Anti-Venom Market: Company Product Application Footprint
Table 65. Anti-Venom New Market Entrants and Barriers to Market Entry
Table 66. Anti-Venom Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Anti-Venom Sales Quantity by Region (2018-2023) & (K Vials)
Table 68. Global Anti-Venom Sales Quantity by Region (2024-2029) & (K Vials)
Table 69. Global Anti-Venom Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Anti-Venom Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Anti-Venom Average Price by Region (2018-2023) & (USD/Vial)
Table 72. Global Anti-Venom Average Price by Region (2024-2029) & (USD/Vial)
Table 73. Global Anti-Venom Sales Quantity by Type (2018-2023) & (K Vials)
Table 74. Global Anti-Venom Sales Quantity by Type (2024-2029) & (K Vials)
Table 75. Global Anti-Venom Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Anti-Venom Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Anti-Venom Average Price by Type (2018-2023) & (USD/Vial)
Table 78. Global Anti-Venom Average Price by Type (2024-2029) & (USD/Vial)
Table 79. Global Anti-Venom Sales Quantity by Application (2018-2023) & (K Vials)
Table 80. Global Anti-Venom Sales Quantity by Application (2024-2029) & (K Vials)
Table 81. Global Anti-Venom Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Anti-Venom Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Anti-Venom Average Price by Application (2018-2023) & (USD/Vial)
Table 84. Global Anti-Venom Average Price by Application (2024-2029) & (USD/Vial)
Table 85. North America Anti-Venom Sales Quantity by Type (2018-2023) & (K Vials)
Table 86. North America Anti-Venom Sales Quantity by Type (2024-2029) & (K Vials)
Table 87. North America Anti-Venom Sales Quantity by Application (2018-2023) & (K Vials)
Table 88. North America Anti-Venom Sales Quantity by Application (2024-2029) & (K Vials)
Table 89. North America Anti-Venom Sales Quantity by Country (2018-2023) & (K Vials)
Table 90. North America Anti-Venom Sales Quantity by Country (2024-2029) & (K Vials)
Table 91. North America Anti-Venom Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Anti-Venom Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Anti-Venom Sales Quantity by Type (2018-2023) & (K Vials)
Table 94. Europe Anti-Venom Sales Quantity by Type (2024-2029) & (K Vials)
Table 95. Europe Anti-Venom Sales Quantity by Application (2018-2023) & (K Vials)
Table 96. Europe Anti-Venom Sales Quantity by Application (2024-2029) & (K Vials)
Table 97. Europe Anti-Venom Sales Quantity by Country (2018-2023) & (K Vials)
Table 98. Europe Anti-Venom Sales Quantity by Country (2024-2029) & (K Vials)
Table 99. Europe Anti-Venom Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Anti-Venom Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Anti-Venom Sales Quantity by Type (2018-2023) & (K Vials)
Table 102. Asia-Pacific Anti-Venom Sales Quantity by Type (2024-2029) & (K Vials)
Table 103. Asia-Pacific Anti-Venom Sales Quantity by Application (2018-2023) & (K Vials)
Table 104. Asia-Pacific Anti-Venom Sales Quantity by Application (2024-2029) & (K Vials)
Table 105. Asia-Pacific Anti-Venom Sales Quantity by Region (2018-2023) & (K Vials)
Table 106. Asia-Pacific Anti-Venom Sales Quantity by Region (2024-2029) & (K Vials)
Table 107. Asia-Pacific Anti-Venom Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Anti-Venom Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Anti-Venom Sales Quantity by Type (2018-2023) & (K Vials)
Table 110. South America Anti-Venom Sales Quantity by Type (2024-2029) & (K Vials)
Table 111. South America Anti-Venom Sales Quantity by Application (2018-2023) & (K Vials)
Table 112. South America Anti-Venom Sales Quantity by Application (2024-2029) & (K Vials)
Table 113. South America Anti-Venom Sales Quantity by Country (2018-2023) & (K Vials)
Table 114. South America Anti-Venom Sales Quantity by Country (2024-2029) & (K Vials)
Table 115. South America Anti-Venom Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Anti-Venom Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Anti-Venom Sales Quantity by Type (2018-2023) & (K Vials)
Table 118. Middle East & Africa Anti-Venom Sales Quantity by Type (2024-2029) & (K Vials)
Table 119. Middle East & Africa Anti-Venom Sales Quantity by Application (2018-2023) & (K Vials)
Table 120. Middle East & Africa Anti-Venom Sales Quantity by Application (2024-2029) & (K Vials)
Table 121. Middle East & Africa Anti-Venom Sales Quantity by Region (2018-2023) & (K Vials)
Table 122. Middle East & Africa Anti-Venom Sales Quantity by Region (2024-2029) & (K Vials)
Table 123. Middle East & Africa Anti-Venom Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Anti-Venom Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Anti-Venom Raw Material
Table 126. Key Manufacturers of Anti-Venom Raw Materials
Table 127. Anti-Venom Typical Distributors
Table 128. Anti-Venom Typical Customers
List of Figures
Figure 1. Anti-Venom Picture
Figure 2. Global Anti-Venom Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-Venom Consumption Value Market Share by Type in 2022
Figure 4. Polyvalent Anti-Venom Examples
Figure 5. Monovalent Anti-Venom Examples
Figure 6. Global Anti-Venom Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Anti-Venom Consumption Value Market Share by Application in 2022
Figure 8. Non-profit Institutions Examples
Figure 9. Hospitals and Clinic Examples
Figure 10. Global Anti-Venom Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Anti-Venom Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Anti-Venom Sales Quantity (2018-2029) & (K Vials)
Figure 13. Global Anti-Venom Average Price (2018-2029) & (USD/Vial)
Figure 14. Global Anti-Venom Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Anti-Venom Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Anti-Venom by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Anti-Venom Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Anti-Venom Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Anti-Venom Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Anti-Venom Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Anti-Venom Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Anti-Venom Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Anti-Venom Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Anti-Venom Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Anti-Venom Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Anti-Venom Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Anti-Venom Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Anti-Venom Average Price by Type (2018-2029) & (USD/Vial)
Figure 29. Global Anti-Venom Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Anti-Venom Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Anti-Venom Average Price by Application (2018-2029) & (USD/Vial)
Figure 32. North America Anti-Venom Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Anti-Venom Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Anti-Venom Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Anti-Venom Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Anti-Venom Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Anti-Venom Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Anti-Venom Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Anti-Venom Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Anti-Venom Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Anti-Venom Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Anti-Venom Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Anti-Venom Consumption Value Market Share by Region (2018-2029)
Figure 52. China Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Anti-Venom Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Anti-Venom Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Anti-Venom Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Anti-Venom Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Anti-Venom Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Anti-Venom Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Anti-Venom Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Anti-Venom Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Anti-Venom Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Anti-Venom Market Drivers
Figure 73. Anti-Venom Market Restraints
Figure 74. Anti-Venom Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Anti-Venom in 2022
Figure 77. Manufacturing Process Analysis of Anti-Venom
Figure 78. Anti-Venom Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
